Clinical Trials on Multiple Sclerosis

Total 10027 results

City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Lymphoma | Multiple Myeloma and Plasma Cell Neoplasm

United States
Temple University

Completed

High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis

Multiple Myeloma and Plasma Cell Neoplasm

United States
WiSP Wissenschaftlicher Service Pharma GmbH
Ludwig-Maximilians - University of Munich; Chugai Pharma GmbH

Completed

Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy (CU01)

Hodgkin's Disease | Non-Hodgkin Lymphomas | Multiple Myelomas
Sohag University

Recruiting

Uses of Titanium Nail in Pediatric Fractures

Fracture of Distal End of Radius | Trauma Injury of Upper Extremity Forearm Multiple

Egypt
Tanta University

Recruiting

Ultrasound- Guided Continuous Retro Laminar Block Versus Continuous Erector Spinae Plane Block in Multiple Rib Fractures

Pain | Erector Spinae Plane Block | Spirometry | Retrolaminar Block | Multiple Rib Fractures

Egypt
Ono Pharmaceutical Co. Ltd

Recruiting

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Multiple System Atrophy (MSA)

United States
GI Cell, Inc.

Recruiting

A Study of GIC-102 (Allogeneic Natural Killer Cells) in Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, and Multiple Myeloma

Advanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin Lymphoma

Korea, Republic of
National Cancer Institute (NCI)

Active, not recruiting

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma
National Cancer Institute (NCI)

Active, not recruiting

Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)

Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma | Hematopoietic and Lymphatic System Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)

Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma | Hematopoietic and Lymphatic System Neoplasm

United States
Biohaven Pharmaceuticals, Inc.

No longer available

Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)

Multiple System Atrophy (MSA)

United States
University of British Columbia

Suspended

Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project

Exostoses, Multiple Hereditary

Canada
Novartis Pharmaceuticals

Completed

Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma

Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma

Italy, Australia, Germany, Spain, France, Japan, United States
Celyad Oncology SA

Unknown

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications (THINK)

Acute Myeloid Leukemia/Myelodysplastic Syndrome | Multiple Myeloma (MM)

United States, Belgium
University Hospital, Bordeaux

Completed

Oligomeric Alpha-synuclein in Multiple System Atrophy (BIOAMS)

Multiple System Atrophy (MSA)

France
Masonic Cancer Center, University of Minnesota

Terminated

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Lymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Germ Cell Tumor

United States
AstraZeneca

Completed

AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients

Multiple System Atrophy, MSA

United States, Finland, Austria, France, Sweden, United Kingdom, Italy
Austrian Forum Against Cancer

Unknown

Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure

Multiple Myeloma Light Chain Induced Renal Insufficiency

Austria, Czech Republic
Genzyme, a Sanofi Company

Completed

A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Thyroid Cancer

Italy, Spain, Romania, Netherlands, Canada, United States, Switzerland, Australia
PharmAust Ltd
Macquarie University, Australia; Calvary Health Care Bethlehem

Recruiting

An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease

Motor Neuron Disease

Australia
University of Bath
National Institute for Health Research, United Kingdom; Earswitch Ltd.

Not yet recruiting

Technical Evaluation of Earswitch Phase B

Motor Neuron Disease
Centro Universitário Augusto Motta

Recruiting

Rehabilitation Program in Patients With Scleroderma

Quality of Life | Exercise | Physical Disability | Scleroderma | Muscle Strain | System; Sclerosis

Brazil
University Hospital, Lille

Recruiting

Study of Predictive Factors of Progression of Motor Neurone Disease (PULSE)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

France
King's College Hospital NHS Trust
Manchester Metropolitan University

Completed

Surface EMG and Ultrasound in MND

Motor Neuron Disease

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Completed

Telehealth in Motor Neurone Disease (TiM)

Motor Neuron Disease

United Kingdom
Tongji Hospital

Not yet recruiting

A Real-world Study for Patients With Multiple Pulmonary Ground-glass Nodules

Multiple Pulmonary Nodules

China
Medical University of Graz

Active, not recruiting

The AT-REBOA Target Trial (AT-REBOA)

Hemorrhage | Polytrauma | Shock, Traumatic | Cardiac Arrest Due to Trauma

Austria
Virta Health

Active, not recruiting

Virta Health Registry

Disease Progression | Chronic Disease | Telemedicine | Multiple Chronic Conditions | Long-Term Care

United States
Assistance Publique - Hôpitaux de Paris

Completed

Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision) (PLH-Vision)

Profound Multiple Intellectual Disabilities

France
National Heart, Lung, and Blood Institute (NHLBI)

Completed

dbGaP Protocol: Genetic Variants Associated With Pentalogy of Cantrell

Pentalogy of Cantrell

United States
Theagenio Cancer Hospital

Completed

Fast Track Rehabilitation Following Video-assisted Lung Segmentectomy

Multiple Pulmonary Nodules

Greece
Seoul National University Bundang Hospital

Active, not recruiting

Factors Associated With Success of NIPPV in ALS Patients

ALS

Korea, Republic of
Monica Healthcare Ltd
New York Presbyterian Hospital

Terminated

Study to Support Fetal Heart Rate and Uterine Contraction for Preterm Labor in Singleton and Multiple Pregnancies

Multiple Pregnancy | Pre Term Labor

United States
Powell Mansfield Inc.

Completed

Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx

Healthy | Amyotrophic Lateral Sclerosis | Obstructive Sleep Apnea | Muscular Dystrophies

United States
Cytora Ltd.

Recruiting

Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early- to Moderate Stage MSA

Multiple System Atrophy | MSA - Multiple System Atrophy

Israel
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

Monoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
Amgen

Active, not recruiting

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia

United States, Australia, Japan, Germany, Canada
National Cancer Institute (NCI)

Active, not recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
Istituto Ortopedico Rizzoli

Completed

Height, Ulnar Length and Forearm Function in Multiple Hereditary Exostoses

Exostoses, Multiple Hereditary

Italy
National Institute of Diabetes and Digestive and...

Completed

Studies of Elevated Parathyroid Activity

Hyperparathyroidism | Multiple Endocrine Neoplasia | Hypercalcemia | MEN1 | Parathyroid Neoplasm

United States
University of Malaya

Completed

Rehabilitation Needs of the Malaysian Haematological Cancer Survivors

Quality of Life | Lymphoma | Blood Cancer | Myeloma Multiple | Haematological Malignancy | Leukemia, Acute

Malaysia
Mayo Clinic
National Cancer Institute (NCI)

Completed

Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma

Plasma Cell Myeloma | Smoldering Plasma Cell Myeloma | Indolent Plasma Cell Myeloma

United States
Samsung Medical Center

Unknown

tDCS for Multiple System Atrophy With Cerebellar Feature

Multiple System Atrophy, Cerebellar Variant (Disorder)

Korea, Republic of
National Cancer Institute (NCI)

Completed

Imaging in MGUS, SMM and MM

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
Janssen Research & Development, LLC

Completed

A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell Neoplasm

United States, Belgium, Russian Federation
Medical College of Wisconsin

Unknown

Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers

Lymphoma | Multiple Myeloma and Plasma Cell Neoplasm

United States

Clinical Trials on Multiple Sclerosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations